Please assess the completion status of the following clinical trial:

Trial Title: RIsk of Apoplexia Cerebri in CLOpidogrel Non-responders

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients admitted to neurological department with stroke signs om CT or MRI or history consistent with stroke and gives clopidogrel 75 mg as prophylactic treatment.~Exclusion Criteria:~* cancer diagnosis Other anti platelet treatment

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Stroke (Type: None): clopidogrel 75 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).